L&G
DOCT.L
IE00BK5BC677
L&G Healthcare Technology & Innovation UCITS ETF
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
27.83
Weighted Fwd P/E
29.95
Avg P/FCF
29.92
Avg FCF Yield
2.55%
Avg EV / EBITDA
28.87
Avg EV / Revenue
14.67
Avg Price-to-Book (P/B)
10.93
Avg Price-to-Sales (P/S)
17.71
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
+7.61%
Avg Debt-to-Equity (D/E)
73.58%
<50% (46.71%) 50-150% (34.24%) >150% (13.46%) Unreported (5.58%)

Profitability Analysis

61 Holdings Count
Profitable 76.73%
Profitable 76.73%
49 Holdings Count (80.33%)
Unprofitable 23.27%
12 Holdings Count (19.67%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

Broadly Diversified
Top 5
12.4%
Top 10
22.8%
Top 25
49.8%
50% Threshold
Top 26
The top 10 make up only 22.8%. Very balanced distribution with minimal single-stock risk. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

10 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (18.8%+)
High (48.8%+)
Top (67.5%+)

Country Breakdown

Max: 75.04%
US US US
75.04%
CH CH CH
8.21%
GB GB GB
3.79%
NL NL NL
3.20%
HK HK HK
2.17%
DE DE DE
1.78%
LU LU LU
1.73%
CN CN CN
1.56%
IT IT IT
1.38%
JP JP JP
1.14%

Sector Distribution

2 Sector
Healthcare
98.51%
Technology
1.49%

Industry Distribution

10 Industries
Diagnostics & Research
33.41%
Medical Devices
28.76%
Biotechnology
18.84%
Medical Instruments & Supplies
5.27%
Health Information Services
4.58%
Drug Manufacturers - General
2.78%
Pharmaceutical Retailers
2.49%
Other
3.87%

Market Cap Distribution

61 Holdings Count
Mega Cap (> 200B)
(2) 3.61%
Large Cap (10B - 200B)
(32) 54.91%
Mid Cap (2B - 10B)
(19) 31.44%
Small / Micro Cap (< 2B)
(8) 10.04%
ende